Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2
- PMID: 1696288
- PMCID: PMC502494
- DOI: 10.1136/jcp.43.6.448
Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2
Abstract
Paraffin wax embedded, formalin fixed sections of 22 adenocarcinomas of the exocrine pancreas were stained with four mouse monoclonal antibodies: DD9-E7, an antibody raised against a human pancreatic tumour xenograft; carcino-embryonic antigen (CEA); epithelial membrane antigen (EMA); and cytokeratin (CAM 5.2). An indirect immunoperoxidase technique without enzyme pre-digestion and an affinity-purified sheep anti-mouse peroxidase conjugate were used. All of the tumours were positive for DD9-E7, EMA, and CAM 5.2. Twenty out of 22 were focally positive for CEA and the staining was often weak. As all of these adenocarcinomas were DD9-E7 positive, absence of staining for DD9-E7 in a tumour makes the diagnosis of adenocarcinoma of the exocrine pancreas very unlikely, and this is of value in distinction from endocrine carcinomas with a marked acinar pattern. The weak CEA staining distinguished pancreatic carcinomas from colorectal tumours. Because the distribution of staining for EMA and CAM 5.2 was no different from that previously seen in adenocarcinomas from other sites, these markers are likely to be of limited value in the differential diagnosis of abdominal adenocarcinomas of uncertain origin.
Similar articles
-
The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.Br J Obstet Gynaecol. 1991 Jan;98(1):73-83. doi: 10.1111/j.1471-0528.1991.tb10315.x. Br J Obstet Gynaecol. 1991. PMID: 1705435
-
Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum.Gut. 1989 Sep;30(9):1260-5. doi: 10.1136/gut.30.9.1260. Gut. 1989. PMID: 2806995 Free PMC article.
-
Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.Am J Dermatopathol. 1994 Jun;16(3):241-6. doi: 10.1097/00000372-199406000-00003. Am J Dermatopathol. 1994. PMID: 7524376
-
Collision of transitional cell carcinoma and renal cell carcinoma. An immunohistochemical study and review of the literature.Cancer. 1994 Jan 1;73(1):154-9. doi: 10.1002/1097-0142(19940101)73:1<154::aid-cncr2820730126>3.0.co;2-k. Cancer. 1994. PMID: 7506117 Review.
-
Mucoepidermoid carcinoma of the anal canal: an immunohistochemical study.J Gastroenterol. 2001 Jul;36(7):508-14. doi: 10.1007/s005350170077. J Gastroenterol. 2001. PMID: 11480798 Review.
Cited by
-
Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.PLoS One. 2013 Nov 21;8(11):e81283. doi: 10.1371/journal.pone.0081283. eCollection 2013. PLoS One. 2013. PMID: 24278411 Free PMC article.
-
A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.Virchows Arch. 2003 May;442(5):444-52. doi: 10.1007/s00428-003-0784-4. Epub 2003 Apr 12. Virchows Arch. 2003. PMID: 12692724
-
Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Clin Cancer Res. 2018 May 15;24(10):2241-2250. doi: 10.1158/1078-0432.CCR-16-3169. Epub 2017 Dec 21. Clin Cancer Res. 2018. PMID: 29269376 Free PMC article. Review.
-
Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.BMJ. 1993 Jan 30;306(6873):295-8. doi: 10.1136/bmj.306.6873.295. BMJ. 1993. PMID: 8461645 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials